Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Hepatol. Mar 27, 2012; 4(3): 105-109
Published online Mar 27, 2012. doi: 10.4254/wjh.v4.i3.105
Table 1 Comparison of IL-18 gene promoter polymorphism between patients with chronic hepatitis B and controls
PositionPolymorphismControl
Patient
X2P valueOR (95% CI)
n = 301 (%)n = 501 (%)
rs1946518AA60 (0.199)141 (0.281)6.7420.0091.573 (1.116-2.218)
AC156 (0.518)239 (0.477)1.2790.2580.848 (0.637-1.129)
CC85 (0.269)121 (0.242)1.4370.2000.809 (0.585-1.119)
A276 (0.279)521 (0.619)10.840.0171.279 (1.045-1.567)
C326 (0.622)481 (0.381)
rs574424CC127 (0.422)198 (0.395)0.5570.4560.895 (0.670-1.197)
GC134 (0.445)232 (0.463)0.2430.6221.075 (0.806-1.433)
GG40 (0.133)71 (0.142)0.1230.7511.070 (0.705-1.623)
C388 (0.645)628 (0.627)0.5120.4750.926 (0.750-1.149)
G214 (0.355)374 (0.373)
Table 2 Haplotype frequencies of two interleukin-18 bi-allelic polymorphisms in chronic hepatitis B and healthy controls
Haplotypesrs1946518rs574424Controls(%)Patients(%)X2P value
IAC62 (10.3)147 (14.7)2.020.155
IIAG214 (35.5)374 (37.3)0.5110.475
IIICC326 (54.2)481 (48.0)2.6230.101